Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5

The incidence of hypertension and diabetes is increasing, it is reported that adipocytokines might be involved in the pathogenesis of diabetes and hypertension. We aimed to investigate the features of adipocytokines, included of Leptin, Irisin, LGR4, and Sfrp5 in type 2 diabetes mellitus (T2DM) pati...

Full description

Bibliographic Details
Main Authors: Baoxin Li, Qi Yao, Shuqin Guo, Shuang Ma, Yuehua Dong, Huanhuan Xin, He Wang, Lifang Liu, Wenlong Chang, Yunliang Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2019-10-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:http://dx.doi.org/10.1080/10641963.2018.1529779
_version_ 1797681386694377472
author Baoxin Li
Qi Yao
Shuqin Guo
Shuang Ma
Yuehua Dong
Huanhuan Xin
He Wang
Lifang Liu
Wenlong Chang
Yunliang Zhang
author_facet Baoxin Li
Qi Yao
Shuqin Guo
Shuang Ma
Yuehua Dong
Huanhuan Xin
He Wang
Lifang Liu
Wenlong Chang
Yunliang Zhang
author_sort Baoxin Li
collection DOAJ
description The incidence of hypertension and diabetes is increasing, it is reported that adipocytokines might be involved in the pathogenesis of diabetes and hypertension. We aimed to investigate the features of adipocytokines, included of Leptin, Irisin, LGR4, and Sfrp5 in type 2 diabetes mellitus (T2DM) patients with hypertension, simultaneously analyzed the connection of the alteration of adipocytokines with blood pressure and glucose. 424 patients with T2DM and 90 healthy subjects were included in the study. The patients with T2DM were divided into 4 groups based on the blood pressure. The levels of adipocytokines (Leptin, Irisin, LGR4, and Sfrp5) were determined by enzyme-linked immunosorbent assay (ELISA). Significantly higher levels of Leptin and lower levels of Irisin, LGR4 and Sfrp5 were seen in patients with diabetes compared with non-diabetes (P < 0.05), the mean values of Leptin level was ascending and Irisin, LGR4, and Sfrp5 levels were declining with promoting of blood pressure in hypertension as compared to the non-hypertension with diabetic patients. Multiple stepwise linear regression analysis showed that the concentrations of Leptin, Irisin, Sfrp5, and LGR4 were found to be closely associated with the control of blood pressure and glucose. Conclusion: Four adipocytokines might play different roles and closely relate to the occurrence and development of diabetes and hypertension.
first_indexed 2024-03-11T23:44:12Z
format Article
id doaj.art-9cc9043bc8cb4aaa98e4708f4600cabd
institution Directory Open Access Journal
issn 1064-1963
1525-6006
language English
last_indexed 2024-03-11T23:44:12Z
publishDate 2019-10-01
publisher Taylor & Francis Group
record_format Article
series Clinical and Experimental Hypertension
spelling doaj.art-9cc9043bc8cb4aaa98e4708f4600cabd2023-09-19T15:19:27ZengTaylor & Francis GroupClinical and Experimental Hypertension1064-19631525-60062019-10-0141764565010.1080/10641963.2018.15297791529779Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5Baoxin Li0Qi Yao1Shuqin Guo2Shuang Ma3Yuehua Dong4Huanhuan Xin5He Wang6Lifang Liu7Wenlong Chang8Yunliang Zhang9Baoding NO.1 Central HospitalBaoding NO.1 Central HospitalBaoding NO.1 Central HospitalBaoding NO.1 Central HospitalBaoding NO.1 Central HospitalBaoding NO.1 Central HospitalBaoding NO.1 Central HospitalBaoding NO.1 Central HospitalBaoding NO.1 Central HospitalBaoding NO.1 Central HospitalThe incidence of hypertension and diabetes is increasing, it is reported that adipocytokines might be involved in the pathogenesis of diabetes and hypertension. We aimed to investigate the features of adipocytokines, included of Leptin, Irisin, LGR4, and Sfrp5 in type 2 diabetes mellitus (T2DM) patients with hypertension, simultaneously analyzed the connection of the alteration of adipocytokines with blood pressure and glucose. 424 patients with T2DM and 90 healthy subjects were included in the study. The patients with T2DM were divided into 4 groups based on the blood pressure. The levels of adipocytokines (Leptin, Irisin, LGR4, and Sfrp5) were determined by enzyme-linked immunosorbent assay (ELISA). Significantly higher levels of Leptin and lower levels of Irisin, LGR4 and Sfrp5 were seen in patients with diabetes compared with non-diabetes (P < 0.05), the mean values of Leptin level was ascending and Irisin, LGR4, and Sfrp5 levels were declining with promoting of blood pressure in hypertension as compared to the non-hypertension with diabetic patients. Multiple stepwise linear regression analysis showed that the concentrations of Leptin, Irisin, Sfrp5, and LGR4 were found to be closely associated with the control of blood pressure and glucose. Conclusion: Four adipocytokines might play different roles and closely relate to the occurrence and development of diabetes and hypertension.http://dx.doi.org/10.1080/10641963.2018.1529779diabeteshypertensionleptinirisinlgr4sfrp5
spellingShingle Baoxin Li
Qi Yao
Shuqin Guo
Shuang Ma
Yuehua Dong
Huanhuan Xin
He Wang
Lifang Liu
Wenlong Chang
Yunliang Zhang
Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5
Clinical and Experimental Hypertension
diabetes
hypertension
leptin
irisin
lgr4
sfrp5
title Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5
title_full Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5
title_fullStr Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5
title_full_unstemmed Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5
title_short Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5
title_sort type 2 diabetes with hypertensive patients results in changes to features of adipocytokines leptin irisin lgr4 and sfrp5
topic diabetes
hypertension
leptin
irisin
lgr4
sfrp5
url http://dx.doi.org/10.1080/10641963.2018.1529779
work_keys_str_mv AT baoxinli type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT qiyao type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT shuqinguo type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT shuangma type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT yuehuadong type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT huanhuanxin type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT hewang type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT lifangliu type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT wenlongchang type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5
AT yunliangzhang type2diabeteswithhypertensivepatientsresultsinchangestofeaturesofadipocytokinesleptinirisinlgr4andsfrp5